Supported by Rep. Anthony Brown, House Foreign Affairs Chairman Eliot Engel, House Armed Services Chairman Adam Smith, House Rules Chairman Jim McGovern, Rep. Elissa Slotkin, Rep. Andy Levin, Rep. Anna Eshoo, Rep. Seth Moulton, Rep. Biggs, Rep. Jim Himes, and many others
Washington, DC – Today, Rep. Ro Khanna (CA-17), Rep. Matt Gaetz (FL-1), and 17 original cosponsors introduced an amendment to the annual National Defense Authorization Act (NDAA) to prevent federal funds from being used for any military force against Iran without congressional authorization.
San Jose – On Tuesday June 18, as reported in the San Francisco Chronicle, Lam Le and Hiep Nguyen were granted temporary visas in order to provide life-saving medical bone marrow to their brother, Tu Le of San Jose, who is undergoing treatment for a rare form of blood cancer known as myelodysplastic syndrome.
Washington, DC – Reps.
Washington, DC – Today, Representatives Ro Khanna (CA-17), Anthony Brown (MD-04), John Garamendi (CA-03), and Seth Moulton (MA-06) released the following statement after withdrawing an amendment to the FY20 National Defense Authorization Act (NDAA) to prohibit the Trump administration from putting the United States on the path to war with Iran without Congressional authorization.
Washington, DC – Today, Rep. Khanna of the HASC, Budget, and Oversight committees, introduced a series of amendments in the NDAA markup. A summary of the amendments is below:
Washington, DC – Today, Rep. Khanna issued the below statement to provide an update on his work to end U.S. complicity in the war in Yemen.
Santa Clara, Ca. – Today, the Congressional Management Foundation (CMF) announced that Rep.
Silicon Valley – Today, Rep. Khanna of the oversight committee issued the following statement in response to the announcement from Special Counsel Robert S. Mueller III that he was closing his office.
Washington, DC – Rep.
Washington, DC – Today, Rep. Ro Khanna joined a bicameral group of lawmakers in introducing the Opioid Crisis Accountability and Results Act, as Vermont Attorney General T. J. Donovan announced a lawsuit today against former Purdue Pharma CEO Richard Sackler and seven family members who served on Purdue’s Board of Directors for deliberately misrepresenting the risks of the drug OxyContin.